• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非侵入性代谢相关脂肪性肝病风险评估方法在重度多囊卵巢综合征患者中相对于采用理想IQ序列的MRI检查的临床实用性。

Clinical Usefulness of Non-Invasive Metabolic-Associated Fatty Liver Disease Risk Assessment Methods in Patients with Full-Blown Polycystic Ovary Syndrome in Relation to the MRI Examination with the Ideal IQ Sequence.

作者信息

Blukacz Łukasz, Nowak Artur, Wójtowicz Mariusz, Krawczyk Angelika, Franik Grzegorz, Madej Paweł, Pluta Dagmara, Kowalczyk Karolina, Żorniak Michał

机构信息

Department of Gynecological Endocrinology, School of Medicine in Katowice, Medical University of Silesia, 40-752 Katowice, Poland.

Gynecological and Obstetrician Polyclinic, 15-435 Białystok, Poland.

出版信息

Biomedicines. 2022 Sep 5;10(9):2193. doi: 10.3390/biomedicines10092193.

DOI:10.3390/biomedicines10092193
PMID:36140294
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9496340/
Abstract

The coexistence of polycystic ovary syndrome (PCOS) and liver steatosis has been studied for years. The gold standards for the diagnosis of liver steatosis are liver biopsy and magnetic resonance imaging (MRI), which are invasive and expensive methods. The main aim of this study is to check the usefulness of lipid accumulation product (LAP) and free androgen index (FAI) in the diagnosis of liver steatosis. The Ideal IQ MRI was performed in 49 women with PCOS phenotype A to assess the degree of liver steatosis, which was expressed with the proton density fat fraction (PDFF). Anthropometric examination and laboratory tests were performed, and the LAP and FAI were calculated. The correlation between MRI results and LAP, FAI, and one of the FAI components, sex hormone binding globulin (SHBG), was checked using statistical tests. There is a statistically significant correlation between PDFF and LAP and also between PDFF and FAI. LAP = 70.25 and FAI = 5.05 were established as cut-offs to diagnose liver steatosis. The SHBG is not a statistically significant parameter to predict liver steatosis. The study showed that especially LAP, but also FAI, can be used to predict liver steatosis with high specificity and sensitivity.

摘要

多囊卵巢综合征(PCOS)与肝脂肪变性的共存已经研究多年。肝脂肪变性诊断的金标准是肝活检和磁共振成像(MRI),这两种方法具有侵入性且费用高昂。本研究的主要目的是检验脂质蓄积产物(LAP)和游离雄激素指数(FAI)在肝脂肪变性诊断中的实用性。对49例A表型PCOS女性进行了Ideal IQ MRI检查,以评估肝脂肪变性程度,用质子密度脂肪分数(PDFF)表示。进行了人体测量检查和实验室检测,并计算了LAP和FAI。使用统计检验检查MRI结果与LAP、FAI以及FAI组分之一性激素结合球蛋白(SHBG)之间的相关性。PDFF与LAP之间以及PDFF与FAI之间存在统计学显著相关性。将LAP = 70.25和FAI = 5.05确定为诊断肝脂肪变性的临界值。SHBG不是预测肝脂肪变性的统计学显著参数。研究表明,尤其是LAP,还有FAI,可用于以高特异性和敏感性预测肝脂肪变性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cb0/9496340/f6ed8e08010e/biomedicines-10-02193-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cb0/9496340/a6ea6cf3ef1e/biomedicines-10-02193-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cb0/9496340/11a94bf851ad/biomedicines-10-02193-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cb0/9496340/f6ed8e08010e/biomedicines-10-02193-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cb0/9496340/a6ea6cf3ef1e/biomedicines-10-02193-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cb0/9496340/11a94bf851ad/biomedicines-10-02193-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cb0/9496340/f6ed8e08010e/biomedicines-10-02193-g003.jpg

相似文献

1
Clinical Usefulness of Non-Invasive Metabolic-Associated Fatty Liver Disease Risk Assessment Methods in Patients with Full-Blown Polycystic Ovary Syndrome in Relation to the MRI Examination with the Ideal IQ Sequence.非侵入性代谢相关脂肪性肝病风险评估方法在重度多囊卵巢综合征患者中相对于采用理想IQ序列的MRI检查的临床实用性。
Biomedicines. 2022 Sep 5;10(9):2193. doi: 10.3390/biomedicines10092193.
2
Establishing the cut off values of androgen markers in the assessment of polycystic ovarian syndrome.确定雄激素标志物在多囊卵巢综合征评估中的临界值。
Malays J Pathol. 2018 Apr;40(1):33-39.
3
Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: assessment of non-invasive indices predicting hepatic steatosis and fibrosis.多囊卵巢综合征女性的非酒精性脂肪性肝病:预测肝脂肪变性和纤维化的非侵入性指标评估
Hormones (Athens). 2014 Oct-Dec;13(4):519-31. doi: 10.14310/horm.2002.1493. Epub 2014 Nov 5.
4
Prospective comparison of transient elastography, MRI and serum scores for grading steatosis and detecting non-alcoholic steatohepatitis in bariatric surgery candidates.对肥胖症手术候选者的肝脂肪变性分级及非酒精性脂肪性肝炎检测中瞬时弹性成像、磁共振成像和血清评分的前瞻性比较
JHEP Rep. 2021 Sep 30;3(6):100381. doi: 10.1016/j.jhepr.2021.100381. eCollection 2021 Dec.
5
Tissue fat quantification by magnetic resonance imaging: proton density fat fraction in polycystic ovary syndrome.磁共振成像技术对组织脂肪进行定量分析:多囊卵巢综合征中的质子密度脂肪分数。
Reprod Biomed Online. 2020 Aug;41(2):329-334. doi: 10.1016/j.rbmo.2020.04.024. Epub 2020 May 15.
6
Fibroscan as a non-invasive predictor of hepatic steatosis in women with polycystic ovary syndrome.Fibroscan 作为多囊卵巢综合征女性肝脂肪变性的非侵入性预测指标。
Indian J Med Res. 2020 Apr;151(4):333-341. doi: 10.4103/ijmr.IJMR_610_18.
7
Circulating osteopontin and its association with liver fat content in non-obese women with polycystic ovary syndrome: a case control study.非肥胖多囊卵巢综合征女性循环骨桥蛋白及其与肝脂肪含量的关系:一项病例对照研究。
Reprod Biol Endocrinol. 2018 Mar 27;16(1):31. doi: 10.1186/s12958-018-0331-4.
8
Quantification of Liver Fat by MRI-PDFF Imaging in Patients with Suspected Non-alcoholic Fatty Liver Disease and Its Correlation with Metabolic Syndrome, Liver Function Test and Ultrasonography.磁共振成像-质子密度脂肪分数成像对疑似非酒精性脂肪性肝病患者肝脏脂肪的定量分析及其与代谢综合征、肝功能检查和超声检查的相关性
J Clin Exp Hepatol. 2021 Sep-Oct;11(5):586-591. doi: 10.1016/j.jceh.2020.11.004. Epub 2020 Dec 1.
9
Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome.雄激素生物利用度增加与多囊卵巢综合征女性的非酒精性脂肪性肝病有关。
Hum Reprod. 2010 Jan;25(1):212-20. doi: 10.1093/humrep/dep380. Epub 2009 Nov 3.
10
Can negligible hepatic steatosis determined by magnetic resonance imaging-proton density fat fraction obviate the need for liver biopsy in potential liver donors?通过磁共振成像质子密度脂肪分数测定的可忽略不计的肝脂肪变性是否可以免除潜在肝供体的肝活检?
Liver Transpl. 2018 Apr;24(4):470-477. doi: 10.1002/lt.24965. Epub 2018 Mar 6.

引用本文的文献

1
Ultrasound-derived fat fraction to assess liver steatosis in obese patients with polycystic ovary syndrome.利用超声测定脂肪分数评估肥胖型多囊卵巢综合征患者的肝脏脂肪变性
Clin Exp Med. 2025 Apr 29;25(1):130. doi: 10.1007/s10238-025-01635-w.
2
Biochemical, sex hormonal, and anthropometric predictors of non-alcoholic fatty liver disease in polycystic ovary syndrome.多囊卵巢综合征中非酒精性脂肪性肝病的生化、性激素及人体测量学预测指标
BMC Womens Health. 2025 Mar 14;25(1):118. doi: 10.1186/s12905-025-03648-9.
3
Evaluation of ultrasound derived fat fraction for metabolic associated fatty liver disease in obese patients with polycystic ovary syndrome.

本文引用的文献

1
Prevalence, Risk Factors, and Pathophysiology of Nonalcoholic Fatty Liver Disease (NAFLD) in Women with Polycystic Ovary Syndrome (PCOS).多囊卵巢综合征(PCOS)女性中非酒精性脂肪性肝病(NAFLD)的患病率、危险因素及病理生理学
Biomedicines. 2022 Jan 7;10(1):131. doi: 10.3390/biomedicines10010131.
2
MAFLD vs. NAFLD: shared features and potential changes in epidemiology, pathophysiology, diagnosis, and pharmacotherapy.MAFLD 与 NAFLD:流行病学、病理生理学、诊断和药物治疗方面的共同特征和潜在变化。
Chin Med J (Engl). 2020 Dec 14;134(1):8-19. doi: 10.1097/CM9.0000000000001263.
3
Polycystic ovary syndrome with feasible equivalence to overweight as a risk factor for non-alcoholic fatty liver disease development and severity in Mexican population.
超声衍生脂肪分数在肥胖多囊卵巢综合征患者代谢相关脂肪性肝病中的评估
J Ultrasound. 2025 Feb 5. doi: 10.1007/s40477-024-00982-w.
4
Quantitative assessment of renal steatosis in patients with type 2 diabetes mellitus using the iterative decomposition of water and fat with echo asymmetry and least squares estimation quantification sequence imaging: repeatability and clinical implications.使用具有回波不对称性和最小二乘估计量化序列成像的水脂迭代分解技术对2型糖尿病患者肾脂肪变性进行定量评估:可重复性及临床意义
Quant Imaging Med Surg. 2024 Oct 1;14(10):7341-7352. doi: 10.21037/qims-24-330. Epub 2024 Sep 23.
多囊卵巢综合征与超重具有等效可能性,是墨西哥人群中非酒精性脂肪性肝病发展和严重程度的一个危险因素。
Ann Hepatol. 2020 May-Jun;19(3):251-257. doi: 10.1016/j.aohep.2020.01.004. Epub 2020 Feb 5.
4
Indirect insulin resistance detection: Current clinical trends and laboratory limitations.间接胰岛素抵抗检测:当前临床趋势及实验室局限性
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2019 Sep;163(3):187-199. doi: 10.5507/bp.2019.021. Epub 2019 Jun 4.
5
Lifestyle changes in women with polycystic ovary syndrome.多囊卵巢综合征女性的生活方式改变
Cochrane Database Syst Rev. 2019 Mar 28;3(3):CD007506. doi: 10.1002/14651858.CD007506.pub4.
6
Recommendations for the management of non-alcoholic fatty liver disease (NAFLD).非酒精性脂肪性肝病(NAFLD)管理建议
Clin Exp Hepatol. 2018 Sep;4(3):153-157. doi: 10.5114/ceh.2018.78118. Epub 2018 Sep 10.
7
Visceral adiposity index for the diagnosis of nonalcoholic fatty liver disease in premenopausal women with and without polycystic ovary syndrome.用于诊断绝经前女性多囊卵巢综合征伴或不伴非酒精性脂肪性肝病的内脏脂肪指数。
Maturitas. 2018 Oct;116:1-7. doi: 10.1016/j.maturitas.2018.06.013. Epub 2018 Jul 4.
8
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.非酒精性脂肪性肝病和非酒精性脂肪性肝炎的全球负担:趋势、预测、危险因素和预防。
Nat Rev Gastroenterol Hepatol. 2018 Jan;15(1):11-20. doi: 10.1038/nrgastro.2017.109. Epub 2017 Sep 20.
9
Lipid accumulation product is a powerful tool to predict non-alcoholic fatty liver disease in Chinese adults.脂质蓄积产物是预测中国成年人非酒精性脂肪性肝病的有力工具。
Nutr Metab (Lond). 2017 Aug 1;14:49. doi: 10.1186/s12986-017-0206-2. eCollection 2017.
10
Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters.超重和/或肥胖以及非肥胖多囊卵巢综合征患者的内脏脂肪指数水平及其与代谢和炎症参数的关系。
J Endocrinol Invest. 2017 May;40(5):487-497. doi: 10.1007/s40618-016-0582-x. Epub 2016 Nov 12.